C-Rad Ab

C-Rad Ab company information, Employees & Contact Information

Explore related pages

Related company profiles:

C-RAD specializes in providing advanced solutions for precise patient positioning, real-time monitoring, tumor localization, and radiation therapy. In modern radiation therapy techniques, delivering radiation doses with unparalleled precision and microsecond timing is essential. Our cutting-edge positioning and scanning products are designed to ensure precisely that level of accuracy. Our customers are radiation treatment clinics and diagnostic departments in hospitals around the globe. Our primary goal is to enhance the quality and efficiency of our customers' clinical outcomes. In June 2015, C-RAD successfully acquired the Franco-Belgian Cyrpa group, enriching our portfolio with innovative laser solutions for patient positioning and virtual simulation. #SGRT #InPositionToMakeADifference

Company Details

Employees
110
Founded
-
Address
Sjukhusvägen 12k, Uppsala,se-753 09,sweden
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
Website
c-rad.com
HQ
Uppsala
Looking for a particular C-Rad Ab employee's phone or email?

C-Rad Ab Questions

News

C-RAD has decided to repurchase own class B shares - TradingView

C-RAD has decided to repurchase own class B shares TradingView

C-RAD has decided to repurchase own class B shares - MarketScreener

C-RAD has decided to repurchase own class B shares MarketScreener

Weiss Ratings Reiterates "Hold (C)" Rating for Radcom (NASDAQ:RDCM) - MarketBeat

Weiss Ratings Reiterates "Hold (C)" Rating for Radcom (NASDAQ:RDCM) MarketBeat

C-RAD Announces Leadership Transition with New Acting CEO - TipRanks

C-RAD Announces Leadership Transition with New Acting CEO TipRanks

James C. "Rad" Weaver - The University of Texas System

James C. "Rad" Weaver The University of Texas System

C-RAD Expedites Q3 2025 Interim Report Approval - TipRanks

C-RAD Expedites Q3 2025 Interim Report Approval TipRanks

C-RAD ABs Interim Report Q3 2025 - MarketScreener

C-RAD ABs Interim Report Q3 2025 MarketScreener

C-RAD showcases new developments at ASTRO 2025 - TradingView

C-RAD showcases new developments at ASTRO 2025 TradingView

Radcom (NASDAQ:RDCM) Given Hold (C) Rating at Weiss Ratings - MarketBeat

Radcom (NASDAQ:RDCM) Given Hold (C) Rating at Weiss Ratings MarketBeat

C-RAD Receives Order for Proton Cancer Treatment Centers in the U.S. - Imaging Technology News

C-RAD Receives Order for Proton Cancer Treatment Centers in the U.S. Imaging Technology News

C-RAD to Present Q3 2025 Interim Report - TipRanks

C-RAD to Present Q3 2025 Interim Report TipRanks

C-RAD advances approval of interim report for Q3 2025 - MarketScreener

C-RAD advances approval of interim report for Q3 2025 MarketScreener

C-RAD at SEETRO 2025: Larisa Van der Bellen on Partnership and Innovation - Oncodaily

C-RAD at SEETRO 2025: Larisa Van der Bellen on Partnership and Innovation Oncodaily

C-RAD | Top Oncology Solutions Company in Europe-2022 - Healthcare Tech Outlook

C-RAD | Top Oncology Solutions Company in Europe-2022 Healthcare Tech Outlook

RaySearch and C-RAD sign collaboration agreement - World Business Outlook

RaySearch and C-RAD sign collaboration agreement World Business Outlook

C Rad : Invitation to presentation of C-RAD's interim report and report for the third quarter 2025 - MarketScreener

C Rad : Invitation to presentation of C-RAD's interim report and report for the third quarter 2025 MarketScreener

C-RAD Expands Czech Market Presence with Key Hospital Order - TipRanks

C-RAD Expands Czech Market Presence with Key Hospital Order TipRanks

Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality - Imaging Technology News

Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Imaging Technology News

C-RAD AB Reports Strong Q3 2025 Earnings and Strategic Growth Initiatives - TipRanks

C-RAD AB Reports Strong Q3 2025 Earnings and Strategic Growth Initiatives TipRanks

C-RAD AB Announces Share Repurchase Program to Optimize Capital Structure - TipRanks

C-RAD AB Announces Share Repurchase Program to Optimize Capital Structure TipRanks

The C-RAD laser system is promoted in the Oncology Clinic, it is expected to be operational within two months - Telegrafi

The C-RAD laser system is promoted in the Oncology Clinic, it is expected to be operational within two months Telegrafi

Home-based intensive treatment of chronic radiation-associated dysphagia in head and neck cancer survivors (HIT-CRAD trial) - BioMed Central

Home-based intensive treatment of chronic radiation-associated dysphagia in head and neck cancer survivors (HIT-CRAD trial) BioMed Central

Will C Rad AB (publ) (24C) stock outperform benchmarks - Sell Signal & Safe Entry Point Identification - newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - Sell Signal & Safe Entry Point Identification newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - 2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - 2025 Top Gainers & Risk Controlled Daily Trade Plans newser.com

C-RAD advances approval of interim report for Q3 2025 - TradingView

C-RAD advances approval of interim report for Q3 2025 TradingView

C-Rad (OM:CRAD B) Profit Margin Decline Challenges Bullish Growth Narratives - simplywall.st

C-Rad (OM:CRAD B) Profit Margin Decline Challenges Bullish Growth Narratives simplywall.st

C-Rad AB Announces Chief Executive Officer Changes - MarketScreener

C-Rad AB Announces Chief Executive Officer Changes MarketScreener

Will C Rad AB (publ) (24C) stock outperform benchmarks - July 2025 Rallies & Stock Timing and Entry Methods - newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - July 2025 Rallies & Stock Timing and Entry Methods newser.com

Substrate rigidity dictates colorectal tumorigenic cell stemness and metastasis via CRAD-dependent mechanotransduction - ScienceDirect.com

Substrate rigidity dictates colorectal tumorigenic cell stemness and metastasis via CRAD-dependent mechanotransduction ScienceDirect.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - Trend Reversal & Low Volatility Stock Recommendations - newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - Trend Reversal & Low Volatility Stock Recommendations newser.com

Elekta to distribute C-RAD’s surface image-guided radiation therapy (SIGRT) solutions in China - DOTmed

Elekta to distribute C-RAD’s surface image-guided radiation therapy (SIGRT) solutions in China DOTmed

How C Rad AB (publ) (24C) stock reacts to weak economy - Price Action & Weekly Market Pulse Alerts - newser.com

How C Rad AB (publ) (24C) stock reacts to weak economy - Price Action & Weekly Market Pulse Alerts newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - 2025 Market Outlook & Community Verified Trade Alerts - newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - 2025 Market Outlook & Community Verified Trade Alerts newser.com

UK Hospital Submits First Order of C-RAD Catalyst System For Breast Cancer Radiation Treatment - radiationtherapynews.com

UK Hospital Submits First Order of C-RAD Catalyst System For Breast Cancer Radiation Treatment radiationtherapynews.com

Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin - Nature

Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin Nature

C-Rad AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

C-Rad AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 MarketScreener

Will C Rad AB (publ) (24C) stock outperform benchmarks - Fed Meeting & Daily Chart Pattern Signal Reports - newser.com

Will C Rad AB (publ) (24C) stock outperform benchmarks - Fed Meeting & Daily Chart Pattern Signal Reports newser.com

SGRT is huge advancement in precision radiotherapy: Debabrata Bhowmick, C-RAD - ET HealthWorld

SGRT is huge advancement in precision radiotherapy: Debabrata Bhowmick, C-RAD ET HealthWorld

CRAD as a cytoskeletal tumour suppressor - Nature

CRAD as a cytoskeletal tumour suppressor Nature

RAD AI CLOSES $60M SERIES C TO FURTHER SOLIDIFY LEADERSHIP IN HEALTHCARE GENERATIVE AI - PR Newswire

RAD AI CLOSES $60M SERIES C TO FURTHER SOLIDIFY LEADERSHIP IN HEALTHCARE GENERATIVE AI PR Newswire

Clarence E. "Man or C-Rad" White Obituary (2024) - Bloomfield, CT - Howard K. Hill Funeral Services - Bloomfield - Legacy obituary

Clarence E. "Man or C-Rad" White Obituary (2024) - Bloomfield, CT - Howard K. Hill Funeral Services - Bloomfield Legacy obituary

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests - Yahoo Finance

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests Yahoo Finance

Elekta to distribute C-RAD SIGRT technology in North America and Mexico - DOTmed

Elekta to distribute C-RAD SIGRT technology in North America and Mexico DOTmed

‘We train to the highest level’: Colorado nonprofit is leading the way for avalanche dog training - Denver7

‘We train to the highest level’: Colorado nonprofit is leading the way for avalanche dog training Denver7

Objectivity’s New CRAD/IRAD Program: Free for Government Partners - GlobeNewswire

Objectivity’s New CRAD/IRAD Program: Free for Government Partners GlobeNewswire

C-Rad AB (FRA:24C) Q3 2025 Earnings Call Highlights: Strong Service Growth Amidst Regional ... By GuruFocus - Investing.com Canada

C-Rad AB (FRA:24C) Q3 2025 Earnings Call Highlights: Strong Service Growth Amidst Regional ... By GuruFocus Investing.com Canada

Late street poet and publishing scourge Crad Kilodney left behind a surprising legacy - The Globe and Mail

Late street poet and publishing scourge Crad Kilodney left behind a surprising legacy The Globe and Mail

FOOTBALL: Crad Jaggers dies at 39 - The News-Enterprise

FOOTBALL: Crad Jaggers dies at 39 The News-Enterprise

Local clubs dominate prestigious Crad Evans Shield | Cairns Local News - Free to read No subscriptions | Local News covering Sport, Entertainment, Real Estate, Community & Business News for Port Douglas, Mossman, Daintree, Gordonvale, Kuranda & Inni - Cairns Local News

Local clubs dominate prestigious Crad Evans Shield | Cairns Local News - Free to read No subscriptions | Local News covering Sport, Entertainment, Real Estate, Community & Business News for Port Douglas, Mossman, Daintree, Gordonvale, Kuranda & Inni Cairns Local News

Author Crad Kilodney was a cranky and courageous fixture on Toronto streets: Fiorito - Toronto Star

Author Crad Kilodney was a cranky and courageous fixture on Toronto streets: Fiorito Toronto Star

Crad Evans Shield: Top footballers take centre stage in Townsville - Townsville Bulletin

Crad Evans Shield: Top footballers take centre stage in Townsville Townsville Bulletin

A connoisseur of the bizarre, Crad Kilodney railed against hypocrisy of the world - The Globe and Mail

A connoisseur of the bizarre, Crad Kilodney railed against hypocrisy of the world The Globe and Mail

Top C-Rad Ab Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant